Description
Induces the expression of TRAIL at 1-5 µM in a p53-independent manner; orally active, stable, and crosses the blood-brain barrier; suppresses the growth of orthotopic human glioblastoma multiforme tumors in mice
Formal name: 2,4,6,7,8,9-hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one
Synonyms: ONC201
Molecular weight: 386.5
CAS: 1616632-77-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|PKB/Akt||Product Type|Biochemicals|Kinase Inhibitors|RAS/RAF/MEK/ERK/MAPK||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer